These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15674424)

  • 1. Dendritic cells in MDS and AML--cause, effect or solution to the immune pathogenesis of disease?
    Panoskaltsis N
    Leukemia; 2005 Mar; 19(3):354-7. PubMed ID: 15674424
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A; Grabrucker C; Kremser A; Dreyssig J; Ansprenger C; Freudenreich M; Kroell T; Reibke R; Tischer J; Schweiger C; Schmid C; Kolb HJ; Schmetzer H
    Cell Immunol; 2010; 265(1):23-30. PubMed ID: 20663492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy.
    Kerkhoff N; Bontkes HJ; Westers TM; de Gruijl TD; Kordasti S; van de Loosdrecht AA
    Immunotherapy; 2013 Jun; 5(6):621-37. PubMed ID: 23725285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
    Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
    J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes.
    Ma L; Delforge M; van Duppen V; Verhoef G; Emanuel B; Boogaerts M; Hagemeijer A; Vandenberghe P
    Leukemia; 2004 Sep; 18(9):1451-6. PubMed ID: 15284864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic characteristics of acute leukaemia after myelodysplastic syndromes.
    Lima M; Teixeira Mdos A; Morais S; Cunha M; Coutinho J; Pinho L; Ribeiro P; Justiça B
    Sangre (Barc); 1995 Feb; 40(1):49-52. PubMed ID: 7716672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P
    Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
    Micheva I; Thanopoulou E; Michalopoulou S; Kakagianni T; Kouraklis-Symeonidis A; Symeonidis A; Zoumbos N
    Br J Haematol; 2004 Sep; 126(6):806-14. PubMed ID: 15352984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.
    Preudhomme C; Lubin R; Lepelley P; Vanrumbeke M; Fenaux P
    Leukemia; 1994 Sep; 8(9):1589-91. PubMed ID: 8090036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.
    Ossenkoppele GJ; van de Loosdrecht AA; Schuurhuis GJ
    Br J Haematol; 2011 May; 153(4):421-36. PubMed ID: 21385170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
    Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
    Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications].
    Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Qian L; Yang T; Yang C; Feng B
    Zhonghua Xue Ye Xue Za Zhi; 1997 Feb; 18(2):80-3. PubMed ID: 15622783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia.
    Houtenbos I; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Haematologica; 2006 Mar; 91(3):348-55. PubMed ID: 16531258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization.
    Houtenbos I; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Immunobiology; 2005; 210(2-4):249-57. PubMed ID: 16164032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.